packageEplontersen

eplontersen

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Eplontersen is an antisense oligonucleotide used to treat familial amyloid polyneuropathy, a hereditary form of nerve damage. It is authorised in the European Union and is a newer medicine, so it is not yet widely used.

Summary written by glm-5.3-flash from Wikidata Q123663227 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:eplontersen
ATC codes:N07XX21
DrugBank:DB16199
Wikidata:Q123663227
molar mass:9046.1 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown